Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Heslegrave

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 21, 2012
Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenaseAmanda J Heslegrave, Khalid Hussain
The Lancet. Healthy Longevity|September 13, 2022
Donanemab removes Alzheimer's plaques: what is special about its target?Deborah O T Alawode, Amanda J Heslegrave, Nick C Fox, et al.
Frontiers in Neuroscience|May 16, 2022
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis StandpointDeborah O T Alawode, Nick C Fox, Henrik Zetterberg, et al.
Frontiers in Cellular Neuroscience|November 15, 2018
Plasma Markers of Neurodegeneration Are Raised in Friedreich's AtaxiaAnna M Zeitlberger, Gilbert Thomas-Black, Hector Garcia-Moreno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2018
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progressionAndrew Geoffrey Bourne Thompson, Connie Luk, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 8, 2025
Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's DiseaseAngeliki Zarkali, George Thomas, Ross Paterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersRobert Durcan, Amanda J Heslegrave, Peter Swann, et al.
Neurobiology of Aging|October 7, 2018
CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementiaWendy E Heywood, Jenny Hallqvist, Amanda J Heslegrave, et al.
Orphanet Journal of Rare Diseases|May 16, 2012
Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA DehydrogenaseAmanda J Heslegrave, Ritika R Kapoor, Simon Eaton, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|December 21, 2012
Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenaseAmanda J Heslegrave, Khalid Hussain
The Lancet. Healthy Longevity|September 13, 2022
Donanemab removes Alzheimer's plaques: what is special about its target?Deborah O T Alawode, Amanda J Heslegrave, Nick C Fox, et al.
Frontiers in Neuroscience|May 16, 2022
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis StandpointDeborah O T Alawode, Nick C Fox, Henrik Zetterberg, et al.
Frontiers in Cellular Neuroscience|November 15, 2018
Plasma Markers of Neurodegeneration Are Raised in Friedreich's AtaxiaAnna M Zeitlberger, Gilbert Thomas-Black, Hector Garcia-Moreno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2018
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progressionAndrew Geoffrey Bourne Thompson, Connie Luk, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 8, 2025
Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's DiseaseAngeliki Zarkali, George Thomas, Ross Paterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersRobert Durcan, Amanda J Heslegrave, Peter Swann, et al.
Neurobiology of Aging|October 7, 2018
CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementiaWendy E Heywood, Jenny Hallqvist, Amanda J Heslegrave, et al.
Orphanet Journal of Rare Diseases|May 16, 2012
Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA DehydrogenaseAmanda J Heslegrave, Ritika R Kapoor, Simon Eaton, et al.
Pageof 6